The Irwin Naturals acquisition drove a 59% year-over-year revenue increase in Q1 2026, offsetting legacy business weakness. The company's diversified brand portfolio spans multiple niche markets within vitamins and nutrition, with Irwin Naturals generating $9–$10 million in annualized revenue on Amazon.
Cyborg Score Rationale
Q4 2025 revenue reached $25.9M (up 73% YoY) and full-year 2025 revenue was $81.5M (up 26% YoY). However, the company faced recent shareholder pressure with a 31% stock decline in late June 2026. Growth is acquisition-dependent, and legacy online business declined.
Top Insights
Strategic acquisition of Irwin Naturals in August 2025 expanded product portfolio and distribution reach
Wholesale revenue surged 156% YoY to $13.2M in Q3 2025 following Irwin acquisition, though online revenue declined 5% YoY
Stock has traded under valuation pressure with 31-34% declines over 90-day period, now trading at forward P/E of 11x vs. industry average of 17x
3-year revenue growth of 27% and earnings per share growth of 22% demonstrate underlying business momentum
Named Competitors
GNC — Vitamin and supplement retailer
Amazon Supplements — E-commerce marketplace for supplements and wellness
Vital Farms — Pasture-raised food company (consumer goods competitor)